Cerebral Dopamine Neurotrophic Factor
AssetAlso CDNF
Neurotrophic factor alleviating endoplasmic reticulum stress and promoting dopamine neuron survival.
- Stage
- Phase 1
- Modality
- Protein or enzyme
- Target
- Proteostasis
- 6
- Indications
- 2
- Trials
- 1
- Developer
Indications
6Brain diseases
Phase 1, Completed, NCT03295786, clinicaltrials.gov, 7 Oct 2026
Movement disorders
Phase 1, Completed, NCT03295786, clinicaltrials.gov, 7 Oct 2026
Nervous system disease
Phase 1, Completed, NCT03295786, clinicaltrials.gov, 7 Oct 2026
3 more
In the full profile
- Targets and what it contains3
- Owner and partners2
- Trials2
- Evidence for its targets2
- Competitors12
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026, 2 sources